- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01155323
Two Week Cross-Over Study Comparing Two Daily Disposable Contact Lenses
June 18, 2018 updated by: Johnson & Johnson Vision Care, Inc.
Proclear 1 Day Lens vs 1-Day Acuvue Moist Daily Disposable Contact Lens Crossover Study
This study seeks to evaluate and compare the clinical performance of two daily disposable soft contact lenses, Proclear 1 Day and 1-Day Acuvue Moist.
Study Overview
Study Type
Interventional
Enrollment (Actual)
118
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore, 139651
- Singapore Plytechnic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- At least 18 years of age and no more than 39 years of age
- Existing soft contact lens wearers
- Willing to signed a written Informed Consent.
- Own a mobile phone and are willing to receive and reply to Short Message Service (SMS) messages during the day.
- Have a contact lens spherical distance requirement between -1.00 diopters (D) and -6.00 diopters (D) in both eyes.
- Have an Astigmatism of 1.00D or less in both eyes.
- Require a visual correction in both eyes.
- Be correctable to a visual acuity of 6/9 (20/30) or better in each eye.
- Have normal eyes with no evidence of abnormality or disease that would preclude lens wear.
Exclusion Criteria:
- Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, tarsal abnormalities, bulbar infection, or any other abnormality of the cornea that would contraindicate contact lens wear.
- Clinically significant corneal staining (Grade 3 in more than one region).
- Keratoconus or other corneal irregularity.
- Abnormal lachrymal secretions.
- Extended wear of contact lenses last 3 months.
- Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in the previous 8 weeks.
- Refractive surgery.
- Eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Require concurrent ocular medication
- Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
- Any infectious disease (e.g., hepatitis, tuberculosis) or any immunosuppressive disease (e.g., HIV).
- Diabetes.
- Pregnant, lactating or planning a pregnancy at the time of enrollment.
- Participation in any concurrent clinical trial or in last 30 days.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: etafilcon A/omafilcon A
etafilcon A contact lenses will be worn during the first week and omafilcon A contact lenses will be worn during the second.
Lenses were replaced daily
|
1-day soft contact lens
1-day soft contact lens
|
|
Active Comparator: omafilcon A/etafilcon A
omafilcon A contact lenses will be worn during the first week and etafilcon A contact lenses will be worn during the second.
Lenses were replaced daily.
|
1-day soft contact lens
1-day soft contact lens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Rating of Comfort
Time Frame: after 1 week of lens wear
|
This outcome is a weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
|
after 1 week of lens wear
|
|
Vision Quality
Time Frame: after 1 week of lens wear
|
This outcome is a weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
|
after 1 week of lens wear
|
|
Subjective Rating of Handling
Time Frame: after 1 week of lens wear
|
This outcome is a weighted combined score calculated from individual lens handling-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
|
after 1 week of lens wear
|
|
Corneal Staining
Time Frame: after 1 week of lens wear
|
Investigator assessment of the corneal staining.
Staining is an indication of dryness on areas on the cornea.
Here it is measured over 5 regions of the cornea: central, temporal, nasal, inferior, and superior.
The staining is graded using the National Eye Institute (NEI)0-3 scale: grade 0 = normal, grade 1 = mild, grade 2 = moderate, grade 3 = severe.
|
after 1 week of lens wear
|
|
Subjective Rating of Quality Perceptions
Time Frame: after 1 week of lens wear
|
This outcome is a weighted combined score calculated from individual quality perception-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
|
after 1 week of lens wear
|
|
Limbal Hyperemia
Time Frame: after 1 week of wear
|
This outcome is assessed by the investigator during biomicroscopy examination using the following 0-4 scale: 0 = none, 1 = trace, 2 = mild, 3= moderate, 4 = severe.
|
after 1 week of wear
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Danny Sim, Diploma in Optometry, Singapore Polytechnic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2010
Primary Completion (Actual)
June 1, 2010
Study Completion (Actual)
June 1, 2010
Study Registration Dates
First Submitted
June 30, 2010
First Submitted That Met QC Criteria
June 30, 2010
First Posted (Estimate)
July 1, 2010
Study Record Updates
Last Update Posted (Actual)
June 19, 2018
Last Update Submitted That Met QC Criteria
June 18, 2018
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR-0926
- DISP-523 (Other Identifier: Visioncare Research Ltd)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.